CARDIOPROGRESS
Foundation for the advancement of cardiology

New Tool Better Estimates Cardiovascular Risk in People With Lupus A tool that incorporates lupus-related variables with traditional risk factors provides a much more accurate assessment of cardiovascular (CV) risk in patients with systemic lupus erythematosus (SLE), according to data presented at the annual meeting of the Canadian Rheumatology Association.

Dapagliflozin Gets Expanded Heart Failure Indication in Europe The European Commission (EC) has expanded the indication for dapagliflozin (Forxiga) to include heart failure (HF) across the full spectrum of left ventricular ejection fraction — including HF with mildly reduced and preserved ejection fraction, AstraZeneca has announced.

Cath Ablation for AF No Less Safe, Effective in Cancer Patients Catheter ablation for atrial fibrillation (AF) is effective and safe in patients with a history of cancer and those receiving cardiotoxic therapies. The ablation success rate in patients with cancer was similar to that observed in patients without cancer.

It’s not just what we eat, but why we eat that’s important for heart health The study found that emotional eating was associated with cardiovascular problems, and that stress contributed to this relationship.

Very Hot, Very Cold Days Tied to Higher CVD Mortality Extremely hot and extremely cold temperatures were associated with a greater risk of cardiovascular mortality in an analysis of data from countries around the world.

Mortality After Acute Stroke Worsened by Accompanying Acute AF Acute atrial fibrillation (AF) is an independent predictor of severity of neurological deficits from early acute ischemic stroke and a high-probability predictor of death within 30 days after such strokes.

24% of Adults With Hypertension Have Subclinical Hypothyroidism The prevalence of subclinical hypothyroidism (SCH) was high, 24%, among people with hypertension in Gansu Province, China. The prevalence was 17% prevalence among normotensive adults from the same region.

Tirzepatide Cuts BP During Obesity Treatment CHICAGO — Treatment with the "twincretin" tirzepatide led to significant and potentially clinically meaningful cuts in 24-hour ambulatory blood pressure, compared with placebo, while causing modest increases in heart rate, in a prespecified substudy of the SURMOUNT-1 trial.

Preeclampsia Linked to Increased Risk for Heart Disease, Stroke in Offspring Preeclampsia is a major cause of maternal and perinatal morbidity and mortality, affecting as many as 5% of pregnancies worldwide. New evidence suggests that the complication doesn't end with delivery.

Four-Drug Combo Gets BP Down in One Step: QUARTET-USA Use of a combination antihypertensive product containing quarter doses of four different drugs could be an effective strategy to get patients to target blood pressures in one step, a new study suggests.

APOE4 May Raise Brain Bleed Risk in Apixaban Users With AF Carriers of the apolipoprotein E epsilon 4 (APOE ε4) allele had a threefold higher risk for intracranial hemorrhage (ICH) when taking apixaban for atrial fibrillation (AF) compared with noncarriers, a new study suggested.

Novel Algorithm Transforms Echocardiographic Assessment of Heart Filling Pressures A new algorithm for estimating left ventricular filling pressure (LVFP) by echocardiography reduced indeterminate results to just two cases compared with 38 using previous guidelines, achieving 86% accuracy in 949 patients, a new study found. The algorithm showed particular improvement for patients with normal left ventricular ejection fraction (LVEF), while maintaining similar accuracy for cases of reduced LVEF.

Longer Sleep Improves Cardiovascular Outcomes: Time to Make Sleep a Priority Causal diagrams demonstrating potential relationships between genetic causes (G) of sleep duration, sleep duration (S), and a cardiovascular outcome (Y). (A) G is a valid instrumental variable for the relationship of S and Y, and can be used to estimated the S–Y association (orange arrow). (B) G has a pleiotropic association with Y. Because there are no unmeasured confounders (U) of the S–Y association, causal mediation analysis can be used to estimate both the direct (pleiotropic) association of G and Y, and the indirect effect via S. (C) The pleiotropic effect of G on Y can be measured by blocking the pathway through S, which is done by conditioning on levels of S. (D) The effect of S on Y independently of G can be measured by blocking pathways through G and C (measured confounders) by conditioning or using matching methods.

Medscape and ACC Centers of Excellence The ACC has collaborated with Medscape to create two Centers of Excellence on the topics of Cardiovascular Risk Reduction and Heart Failure.

AHA Scientific Sessions 2020 and the Resuscitation Science Symposium 2020! Welcome to AHA Scientific Sessions 2020 and the Resuscitation Science Symposium (RESS) 2020!

World Heart Day 2021 World Heart Day is a global health campaign. Its main task is to raise awareness about diseases of the cardiovascular system, the reasons for their occurrence and how to prevent them. For the first time, cardiologists at an international congress in 2012 announced the need to establish a holiday. Then, in the presence of world leaders, shocking numbers were announced. More than 18 million people die from cardiovascular diseases worldwide every year.

What's New in the AHA/ASA Secondary Stroke Prevention Guidelines? Clinical Context Risk for recurrent stroke or TIA is high but can be lowered by appropriate secondary stroke prevention. As secondary stroke prevention strategies have improved in recent years, cohort studies have shown decreased rates of recurrent stroke and transient ischemic attack (TIA).

ESC Congress 2021 ESC Congress is first and foremost a celebration of science. It's all about challenging and inspiring cardiovascular professionals to discover and deliver the best care possible to their patients. It’s widely regarded as THE annual cardiology event in the calendar.

Peripheral arterial disease - indications for intervention: from open surgery to endovascular and hybrid repair Peripheral arterial disease (PAD) is a marker of increased risk of СV mortality and limb loss. Staging of limb ischaemia severity, assessment of patient risk and knowledge of PAD anatomy are essential requirements to improve survival, reduce major cardiovascular events and to treat the ischaemic syndrome.

New Clinical Practice Guideline for the Management of Adult Overweight and Obesity Synopsis summarizes the key recommendations of the guideline regarding management of overweight and obesity, including referral to comprehensive lifestyle interventions that combine behavioral, dietary, and physical activity change, and additional tools of pharmacologic and procedural interventions.